Stoke Therapeutics (STOK) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Stoke Therapeutics (STOK) over the last 4 years, with Q3 2025 value amounting to -$0.65.
- Stoke Therapeutics' EPS (Weighted Average and Diluted) fell 3829.79% to -$0.65 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.68, marking a year-over-year increase of 13238.1%. This contributed to the annual value of -$1.64 for FY2024, which is 3107.19% up from last year.
- Latest data reveals that Stoke Therapeutics reported EPS (Weighted Average and Diluted) of -$0.65 as of Q3 2025, which was down 3829.79% from -$0.4 recorded in Q2 2025.
- Stoke Therapeutics' 5-year EPS (Weighted Average and Diluted) high stood at $1.9 for Q1 2025, and its period low was -$0.69 during Q2 2023.
- In the last 4 years, Stoke Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.57 in 2024 and averaged -$0.39.
- Within the past 5 years, the most significant YoY rise in Stoke Therapeutics' EPS (Weighted Average and Diluted) was 43333.33% (2025), while the steepest drop was 3829.79% (2025).
- Quarter analysis of 4 years shows Stoke Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.65 in 2022, then rose by 5.59% to -$0.61 in 2023, then soared by 67.77% to -$0.2 in 2024, then plummeted by 228.61% to -$0.65 in 2025.
- Its last three reported values are -$0.65 in Q3 2025, -$0.4 for Q2 2025, and $1.9 during Q1 2025.